Case 1:22-cv-00252-MSG Document 193-10 Filed 01/16/24 Page 1 of 5 PageID #: 12638
`Case 1:22-cv-00252-MSG Document 193-10 Filed 01/16/24 Page 1 of 5 PagelD #: 12638
`
`EXHIBIT 10
`EXHIBIT 10
`
`
`Case 1:22-cv-00252-MSG Document 193-10 Filed 01/16/24 Page 1 of 5 PagelD #: 12638
`
`EXHIBIT 10
`EXHIBIT 10
`
`
`
`Case 1:22-cv-00252-MSG Document 193-10 Filed 01/16/24 Page 2 of 5 PageID #: 12639
`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE DISTRICT OF DELAWARE
`
`
`CONTAINS INFORMATION
`MODERNA DESIGNATED HIGHLY
`CONFIDENTIAL – OUTSIDE
`COUNSEL EYES ONLY
`
`C.A. No. 22-252-MSG
`
`)
`)
`)
`
`))
`
`
`)
`)
`
`))
`
`)
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GmbH,
`
`Plaintiffs,
`
`v.
`
`MODERNA, INC. and MODERNATX, INC.,
`
`Defendants.
`
`PLAINTIFFS’ SECOND SET OF INTERROGATORIES TO DEFENDANTS
`
`Pursuant to Federal Rules of Civil Procedure 26 and 33, Plaintiffs Arbutus Biopharma
`
`Corporation (“Arbutus”) and Genevant Sciences GmbH (“Genevant”) request that Defendants
`
`Moderna, Inc. and ModernaTX Inc. (collectively, “Moderna” or “Defendants”) respond fully, in
`
`writing, under oath, separately to each interrogatory below. Plaintiffs request that Defendants
`
`serve their written responses to these interrogatories upon Williams & Connolly LLP, 680 Maine
`
`Avenue SW, Washington, DC, 20024, within 30 days after service hereof.
`
`DEFINITIONS & INSTRUCTIONS
`
`Plaintiffs incorporate herein by reference as though fully set forth herein the definitions
`
`and instructions of Plaintiffs First Set of Interrogatories to Defendants served February 16, 2023.
`
`INTERROGATORY NO. 11
`
`INTERROGATORIES
`
`Identify all final and intermediate batches and/or lots of the Accused Product by all batch
`
`numbers and/or lot numbers, including any batch and/or lot numbers used or assigned by Moderna
`
`or any third party, including:
`
`1
`
`
`
`Case 1:22-cv-00252-MSG Document 193-10 Filed 01/16/24 Page 3 of 5 PageID #: 12640
`
`(1) all batches and/or lots of mRNA-1273 Drug Product and any supplemental or booster
`
`COVID-19 mRNA vaccine product thereof, including any batches and/or lots of mRNA-
`
`1273.214 and mRNA-1273.222;
`
`(2) all batches and/or lots of mRNA-1273 Lipid Nanoparticle (“LNP”), including all batches
`
`and/or lots of mRNA-1273 LNP-B, mRNA-1273.529 LNP, and mRNA-1273.045 LNP;
`
`(3) all batches and/or lots of
`
`;
`
`(4) all batches and/or lots of SM-102, DSPC, Cholesterol, and PEG2000-DMG; and
`
`(5) all batches and/or lots of mRNA, including all batches and/or lots of CX-024414, CX-
`
`034476, and CX-031302,
`
`and for each batch and/or lot:
`
`describe in detail the genealogy of the batch and/or lot, including the source and disposition
`
`of the batch and/or lot, including: the batches of SM-102, DSPC, Cholesterol, and PEG2000-DMG
`
`used to manufacture each batch of
`
`LNP; the batches of mRNA and batches of
`
` and/or mRNA-1273
`
` used
`
`to manufacture each batch of mRNA-1273 LNP; the batches of mRNA-1273 LNP used to
`
`manufacture each batch of mRNA-1273 Drug Product and/or other final drug product; the parties
`
`to whom or by whom the batch and/or lot was manufactured, sold, offered for sale, distributed,
`
`transferred, shipped, administered and/or used; where that manufacturing, sale, offer for sale,
`
`distribution, transfer, shipment, administration and/or use occurred; and the dates on which that
`
`manufacturing, sale, offer for sale, distribution, transfer, shipment, administration and/or use
`
`occurred; and
`
`identify the unit sales, revenues, gross profit, net profit, average unit sales price to end
`
`users, average unit sales price to distributors (if any), list price to end users, list price to distributors
`
`2
`
`
`
`Case 1:22-cv-00252-MSG Document 193-10 Filed 01/16/24 Page 4 of 5 PageID #: 12641
`
`(if any), cost of goods sold (including identification of the items included in cost of goods sold),
`
`and operating costs (i.e., other costs not included in cost of goods sold, such as selling, general,
`
`and administrative expenses) associated with the batch and/or lot.
`
`/s/ Nathan R. Hoeschen
`John W. Shaw (No. 3362)
`Karen E. Keller (No. 4489)
`Nathan R. Hoeschen (No. 6232)
`SHAW KELLER LLP
`I.M. Pei Building
`1105 North Market Street, 12th Floor
`Wilmington, DE 19801
`(302) 298-0700
`jshaw@shawkeller.com
`kkeller@shawkeller.com
`nhoeschen@shawkeller.com
`Attorneys for Plaintiffs
`
`OF COUNSEL:
`David I. Berl
`Adam D. Harber
`Thomas S. Fletcher
`Jessica Palmer Ryen
`Lydia B. Cash
`Shaun P. Mahaffy
`Anthony H. Sheh
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue S.W.
`Washington, DC 20024
`(202) 434-5000
`Attorneys for Plaintiff Genevant
`Sciences GmbH
`
`Daralyn J. Durie
`Shaelyn K. Dawson
`MORRISON & FOERSTER LLP
`425 Market Street
`San Francisco, CA 94105-2482
`(415) 268-6080
`
`Kira A. Davis
`MORRISON & FOERSTER LLP
`707 Wilshire Boulevard
`Los Angeles, CA 90017-3543
`(213) 892-5200
`
`David N. Tan
`MORRISON & FOERSTER LLP
`2100 L Street, NW, Suite 900
`Washington, DC 20037
`Attorneys for Plaintiff Arbutus
`Biopharma Corporation
`
`Dated: March 16, 2023
`
`3
`
`
`
`Case 1:22-cv-00252-MSG Document 193-10 Filed 01/16/24 Page 5 of 5 PageID #: 12642
`
`CERTIFICATE OF SERVICE
`
`I, Nathan R. Hoeschen, hereby certify that on March 16, 2023, this document was served
`
`on the persons listed below in the manner indicated:
`
`BY EMAIL:
`Jack B. Blumenfeld
`Brian P. Egan
`MORRIS, NICHOLS, ARSHT & TUNNELL LLP
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899
`(302) 658-9200
`jblumenfeld@morrisnichols.com
`began@morrisnichols.com
`
`
`
`
`
`
`
`James F. Hurst
`KIRKLAND & ELLIS LLP
`300 North LaSalle
`Chicago, IL 60654
`(312) 862-2000
`james.hurst@kirkland.com
`
`Patricia A. Carson, Ph.D.
`Jeanna M. Wacker
`Mark C. McLennan
`Nancy Kaye Horstman
`KIRKLAND & ELLIS LLP
`601 Lexington Avenue
`New York, NY 10022
`(212) 446-4800
`patricia.carson@kirkland.com
`jeanna.wacker@kirkland.com
`mark.mclennan@kirkland.com
`kaye.horstman@kirkland.com
`
`
`
`
`/s/ Nathan R. Hoeschen
`John W. Shaw (No. 3362)
`Karen E. Keller (No. 4489)
`Nathan R. Hoeschen (No. 6232)
`SHAW KELLER LLP
`I.M. Pei Building
`1105 North Market Street, 12th Floor
`Wilmington, DE 19801
`(302) 298-0700
`jshaw@shawkeller.com
`kkeller@shawkeller.com
`nhoeschen@shawkeller.com
`Attorneys for Plaintiffs
`
`4
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
